cgp 54626 has been researched along with ethosuximide in 1 studies
Studies (cgp 54626) | Trials (cgp 54626) | Recent Studies (post-2010) (cgp 54626) | Studies (ethosuximide) | Trials (ethosuximide) | Recent Studies (post-2010) (ethosuximide) |
---|---|---|---|---|---|
57 | 0 | 16 | 1,096 | 37 | 206 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernasconi, R; Bittiger, H; De Barry, J; Marescaux, C; Mathivet, P | 1 |
1 other study(ies) available for cgp 54626 and ethosuximide
Article | Year |
---|---|
Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist.
Topics: Animals; Anticonvulsants; Baclofen; Binding, Competitive; Brain Chemistry; Ethosuximide; GABA Agonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Guanylyl Imidodiphosphate; In Vitro Techniques; Male; Organophosphorus Compounds; Radioligand Assay; Rats; Rats, Wistar; Receptors, GABA-B; Sodium Oxybate; Valproic Acid | 1997 |